Thrombolytic Therapy in the Current ERA: Myocardial Infarction and Beyond

Curr Pharm Des. 2018;24(4):414-426. doi: 10.2174/1381612824666171227211623.

Abstract

Thrombolytic therapy kick-started the era of modern cardiology but in the last few decades it has been largely supplanted by primary percutaneous coronary intervention (PCI) as the go-to treatment for acute myocardial infarction. However, these agents remain important for vast populations without access to primary PCI and acute ischemic stroke. More innovative uses have recently come up for the treatment of a variety of conditions. This article summarizes the history, evidence base and current use of thrombolytics in cardiovascular disease.

Keywords: Thrombolysis; acute ischemic stroke; acute myocardial infarction; catheter directed thrombolysis; pulmonary embolism; thrombolytic therapy..

Publication types

  • Review

MeSH terms

  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / surgery
  • Percutaneous Coronary Intervention
  • Thrombolytic Therapy*

Substances

  • Fibrinolytic Agents